Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson
McKesson
Moodys

Last Updated: October 14, 2019

DrugPatentWatch Database Preview

AMELUZ Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Ameluz patents expire, and what generic alternatives are available?

Ameluz is a drug marketed by Biofrontera and is included in one NDA. There is one patent protecting this drug.

This drug has thirteen patent family members in eleven countries.

The generic ingredient in AMELUZ is aminolevulinic acid hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aminolevulinic acid hydrochloride profile page.

Drug patent expirations by year for AMELUZ
Drug Prices for AMELUZ

See drug prices for AMELUZ

Recent Clinical Trials for AMELUZ

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Jeffrey B. Travers, MD, PhDEarly Phase 1
Royal Cornwall Hospitals TrustPhase 3
National Cancer Institute (NCI)Phase 2

See all AMELUZ clinical trials

Pharmacology for AMELUZ
Synonyms for AMELUZ
106-60-5
106A605
1354778-41-8
1451AA
33871-EP2275420A1
33871-EP2295055A2
33871-EP2295416A2
33871-EP2298748A2
33871-EP2298764A1
33871-EP2298765A1
33871-EP2305642A2
33871-EP2305825A1
33871-EP2311453A1
33871-EP2311808A1
33871-EP2311829A1
35BEC718-C970-426A-9859-BF58284C60B4
4-Carboxy-2-Oxobutylamine
4-oxo-5-amino-pentanoic acid
5-ALA
5-amino-4-oxo-Pentanoate
5-amino-4-oxo-pentanoic acid
5-Amino-4-oxopentanoate
5-Amino-4-oxopentanoic acid
5-Amino-4-oxopentanoic acid5-amino-4-oxo-pentanoic acid5-amino-4-keto-valeric acid106-60-5CHEBI:17549KBioSS_002062Spectrum_001582Pentanoic acid, 5-
5-Amino-4-oxovalerate
5-Amino-4-oxovaleric acid
5-amino-levulinate
5-amino-levulinic acid
5-Aminolaevulinate
5-Aminolaevulinic acid
5-Aminolevulinate
5-Aminolevulinic acid
5-aminolevulinicacidhydrochloride
5-azanyl-4-oxidanylidene-pentanoic acid
5ALA
88755TAZ87
AB00053763_09
AB00053763_10
AB00053763-07
AB00053763-08
AC-054
AC1L18K9
AJ-45595
AK-41254
AKOS003587520
Aladerm
ALBB-023627
Amino-levulinic acid
Aminolevulinate
Aminolevulinic
Aminolevulinic acid
AN-16185
AN-492
AS-30950
AX8017444
BC205541
BCP23830
BDBM50240386
BF-200 ALA
BIDD:GT0260
BSPBio_003407
C-49907
C00430
CCRIS 8958
CHEBI:17549
CHEMBL601
CPD000857229
CS-W000450
D-aminolevulinic acid
D07567
DALA
DB-040692
DB00855
delta-ALA
delta-aminolevulinate
delta-aminolevulinic acid
DivK1c_006954
DTXSID8048490
EINECS 203-414-1
FCH831578
FT-0620021
FVT
GTPL4784
HMS2231I19
HMS3259E22
HMS3369O14
HY-W000450
I14-10101
KB-244624
KBio1_001898
KBio2_002062
KBio2_004630
KBio2_007198
KBio3_002627
KBioGR_001176
KBioSS_002062
Kerastick
Levulinic acid, 5-amino-
Levulinic acid, 5-amino- (8CI)
LMFA01100055
LS-101793
LS41389
MCULE-8676354165
MLS001333097
MLS001333098
MolPort-001-788-423
NC00601
NCGC00178086-01
PEN029
Pentanoic acid, 5-amino-4-oxo-
Pentanoic acid, 5-amino-4-oxo- (9CI)
SAM002589919
SBB071696
SBI-0206721.P001
SC-15622
SCHEMBL8243
SMR000857229
SPBio_001843
SpecPlus_000858
Spectrum_001582
Spectrum2_001662
Spectrum3_001654
Spectrum4_000618
Spectrum5_001505
ST45026832
UNII-88755TAZ87
Z-3294
ZGXJTSGNIOSYLO-UHFFFAOYSA-N
ZINC3782550
ZX-AN022141

US Patents and Regulatory Information for AMELUZ

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biofrontera AMELUZ aminolevulinic acid hydrochloride GEL;TOPICAL 208081-001 May 10, 2016 RX Yes Yes   See Pricing   See Pricing Y   See Pricing
Biofrontera AMELUZ aminolevulinic acid hydrochloride GEL;TOPICAL 208081-001 May 10, 2016 RX Yes Yes   See Pricing   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Mallinckrodt
Dow
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.